Multivariable HRs for FL patients age <65 years
| . | HR (95% CI) . | P . |
|---|---|---|
| Insurance status | ||
| Private insurance | 1.00 (ref) | |
| No insurance | 1.96 (1.69-2.28) | <.0001 |
| Medicaid | 1.83 (1.57-2.12) | <.0001 |
| Medicare | 1.96 (1.71-2.24) | <.0001 |
| Sex | ||
| Male | 1.00 (ref) | |
| Female | 0.78 (0.71-0.85) | <.0001 |
| Race/ethnicity | ||
| White | 1.00 (ref) | |
| Black | 0.98 (0.83-1.17) | .8462 |
| Hispanic | 0.72 (0.59-0.88) | .0014 |
| Other race | 0.95 (0.81-1.12) | .5616 |
| Unknown race | 1.01 (0.56-1.82) | .9828 |
| Percent with no high school diploma | ||
| <7 | 1.00 (ref) | |
| 7-12.9 | 1.19 (1.05-1.34) | .0051 |
| 13-20.9 | 1.4 (1.24-1.59) | <.0001 |
| >21 | 1.42 (1.22-1.64) | <.0001 |
| B symptoms | ||
| Not present | 1.00 (ref) | |
| Present | 1.35 (1.22-1.49) | <.0001 |
| Stage | ||
| I/II | 1.00 (ref) | |
| III/IV | 1.69 (1.52-1.87) | <.0001 |
| Comorbidity score | ||
| 0 | 1.00 (ref) | |
| 1 | 1.71 (1.52-1.93) | <.0001 |
| 2+ | 3.1 (2.61-3.69) | <.0001 |
| Initial treatment | ||
| Systemic | 1.00 (ref) | |
| None | 0.81 (0.71-0.92) | <.0001 |
| Days to treatment | ||
| 0-14 | 1.00 (ref) | |
| 15-30 | 0.82 (0.73-0.93) | .0012 |
| 30+ | 0.69 (0.62-0.76) | <.0001 |
| . | HR (95% CI) . | P . |
|---|---|---|
| Insurance status | ||
| Private insurance | 1.00 (ref) | |
| No insurance | 1.96 (1.69-2.28) | <.0001 |
| Medicaid | 1.83 (1.57-2.12) | <.0001 |
| Medicare | 1.96 (1.71-2.24) | <.0001 |
| Sex | ||
| Male | 1.00 (ref) | |
| Female | 0.78 (0.71-0.85) | <.0001 |
| Race/ethnicity | ||
| White | 1.00 (ref) | |
| Black | 0.98 (0.83-1.17) | .8462 |
| Hispanic | 0.72 (0.59-0.88) | .0014 |
| Other race | 0.95 (0.81-1.12) | .5616 |
| Unknown race | 1.01 (0.56-1.82) | .9828 |
| Percent with no high school diploma | ||
| <7 | 1.00 (ref) | |
| 7-12.9 | 1.19 (1.05-1.34) | .0051 |
| 13-20.9 | 1.4 (1.24-1.59) | <.0001 |
| >21 | 1.42 (1.22-1.64) | <.0001 |
| B symptoms | ||
| Not present | 1.00 (ref) | |
| Present | 1.35 (1.22-1.49) | <.0001 |
| Stage | ||
| I/II | 1.00 (ref) | |
| III/IV | 1.69 (1.52-1.87) | <.0001 |
| Comorbidity score | ||
| 0 | 1.00 (ref) | |
| 1 | 1.71 (1.52-1.93) | <.0001 |
| 2+ | 3.1 (2.61-3.69) | <.0001 |
| Initial treatment | ||
| Systemic | 1.00 (ref) | |
| None | 0.81 (0.71-0.92) | <.0001 |
| Days to treatment | ||
| 0-14 | 1.00 (ref) | |
| 15-30 | 0.82 (0.73-0.93) | .0012 |
| 30+ | 0.69 (0.62-0.76) | <.0001 |
ref, reference.